|
| |
Clinical
Multimodal and Assessment of Response
Room 4A Wednesday 14:00 - 16:00
|
Time |
Prog # |
Computer# |
|
|
14:00 |
3478 |
25 |
Quantification of
Response of Hepatocellular Carcinoma(HCC) to Bevacizumab by Contrast
Enhanced MRI
Emil Cohen1,
Jonathan Schwartz1, John Mandeli2, Deborah Lehrer2
1Mount
Sinai School of Medicine, New York, New York, USA; 2Mount
Sinai Medical Center, New York, New York, USA |
|
14:00 |
3479 |
26 |
Oncological Imaging:
Whole-Body MRI for Staging of Patients with Malignant Lymphoma
Bernd B.
Frericks1, Bernhard Meyer1, Thomas Albrecht1,
Alexander Huppertz2, Karl J. Wolf1, Frank K.
Wacker1
1Charité,
Campus Benjamin Franklin, Berlin, Germany; 2Siemens, Berlin,
Germany |
|
14:00 |
3480 |
24 |
MRI Compared to CT in
Whole-Body Slice Area Measurements
Joel Kullberg1,
Jan-Erik Angelhed2, John Brandberg2, 3,
Hans Frimmel1, Eva Bergelin2, Lena Strid2,
Håkan Ahlström1,
Lars Johansson1,
Lars Lönn2, 3
1Uppsala
University Hospital, Uppsala, Sweden; 2The Sahlgrenska
Academy at Göteborg University, Göteborg, Sweden;
3Sahlgrenska
University Hospital, Göteborg, Sweden |
|
14:30 |
3481 |
24 |
Whole-Body Pet-MRI -
Co-Registration and Image Fusion in Pattients with Cancer
Roberto Cortes Domingues1, 2,
Michel Pontes Carneiro3, Luiz Celso Hygino da Cruz4,
Karla Sideira Porto4,
Leonardo Pitanga4, Rômulo Cortes Domingues4,
Romeu Cortes Domingues4
1CDPI
/ Multi-Imagem, Rio de Janeiro, RJ, Brazil; 2Multimagem Pet,
Rio de Janeiro, RJ, Brazil; 3Multimagem PET, Rio de Janeiro,
RJ, Brazil; 4CDPI, Rio de Janeiro, RJ, Brazil |
|
14:30 |
3482 |
26 |
Evaluation Early
Response of Hepatocellular Carcinoma After Transcatheter Arterial
Chemoembolizatio
(TACE) with 1H
Magnetic Resonance Spectroscopy In Vivo
Wu Bin1,
Peng Weijuns1
1Cancer
Hospital, Shanghai, People’s Republic of China |
|
14:30 |
3483 |
25 |
Neoadjuvant
Chemotherapy in Breast Cancer: Prediction of Post-Surgery Disease-Free
Survival Using DCE
MRI, Water ADC
Mapping and Proton Spectroscopic Imaging
David John
Manton1, Anne Hubbard2, Martin Lowry1,
Anthony Maraveyas1, Martin D. Pickles1, Daniel J.
Tozer3, Lindsay
W. Turnbull1
1University
of Hull, Hull, East Yorkshire, UK; 2Hull and East Yorkshire
Hospitals NHS Trust, Hull, East Yorkshire, UK;
3Institute
of Neurology, London, UK |
| 15:00 |
3484 |
25 |
Tumor Volume
Regression During Therapy in Cervical Cancer: Does the Tumor Regress
Faster with Combined
Radiation/Chemotherapy Than with Radiation Therapy Alone?
Nina A. Mayr1,
Jian Zhong Wang1, William TC Yuh1, Joseph F.
Montebello1, Vincent A. Magnotta2,
Kenneth F.
Wegner3, Susan M. Edwards3
1The
Ohio State University, Columbus, Ohio, USA; 2University of
Iowa, Iowa City, Iowa, USA; 3University of Oklahoma
Health Science
Center, Oklahoma City, Oklahoma, USA |
| 15:00 |
3485 |
26 |
Diffusion-Weighted
and Dynamic Contrast-Enhanced Imaging at 3.0 T of Prostate Cancer
Uulke Age van der Heide1, Cecile R.L.P.N.
Jeukens1, Peter R. Luijten1, Marco van Vulpen1
1UMC-Utrecht,
Utrecht, Netherlands |
| 15:00 |
3486 |
24 |
Whole Body MR Imaging
vs. FDG-PET: Comparison of Diagnosis Accuracy of M-Stage in Lung Cancer
Patients
Yoshiharu Ohno1,
Hisanobu Koyama1, Munenobu Nogami1, Hideaki
Kawamitsu2, Daisuke Takenaka1,
Kazuro Sugimura1
1Kobe
University Graduate School of Medicine, Kobe, Hyogo, Japan; 2Kobe
University Hospital, Kobe, Hyogo, Japan |
| 15:30 |
3487 |
24 |
Combined Stereoscopic
X-Ray and MR Imaging (“XMR”) for the Evaluation of Prostate
Brachytherapy Implants
with Comparison to
Standard CT-Based Dosimetry
Peter Acher1,
2, Kawal Rhode1, Stephen Morris2, Marc
Miquel1, Kate Mcleish1, Ronald Beaney2,
Charles Deehan2, Rick
Popert2,
Stephen Keevil1
1King's
College London, London, England, UK; 2Guy's & St Thomas' NHS
Foundation Trust, London, England, UK |
| 15:30 |
3488 |
26 |
Combined MRI/MRS
Protocol for Specificity Improvement in Breast Cancer Detection
Luminita Alina
Tudorica1, Paul Fisher1, Khaldoon Dulaimy1,
Brian O'Hea1, Terry Button1, Wei Huang2
1State
University of New York, Stony Brook, New York, USA; 2Memorial
Sloan-Kettering Cancer Center, New York, New
York, USA |
| 15:30 |
3489 |
25 |
Dynamic
Contrast-Enhanced MRI as a Predictor of Residual Tumor After
Photodynamic Therapy with TOOKAD
(WST09) for Locally
Recurrent Prostate Carcinoma After Radiation Therapy
Masoom A.
Haider1, Brian Wilson2, Sean Davidson2,
Robert Weersink2, Mark Gertner2, Andrew Evans2,
Ants Toi1, John
Trachtenberg3
1University
of Toronto, Toronto, Ontario, Canada; 2Princess Margaret
Hospital, Toronto, Ontario, Canada; 3University Health
Network, University of Toronto, Toronto, Ontario, Canada |
|